Return to study ST002191 main page
MB Sample ID: SA210175
Local Sample ID: | F1430 |
Subject ID: | SU002277 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Age Or Age Range: | E18.5 |
Gender: | Male and female |
Animal Housing: | Vivarium University of Colorado Anschutz Medical Campus |
Animal Light Cycle: | 12/12 |
Animal Feed: | CH; D12450B; Research Diets, New Brunswick, NJ, USA or HFD; D12451; Research Diets |
Animal Water: | Water or treated with 1.25 mg/L PQQ |
Select appropriate tab below to view additional metadata details:
Subject:
Subject ID: | SU002277 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Age Or Age Range: | E18.5 |
Gender: | Male and female |
Animal Housing: | Vivarium University of Colorado Anschutz Medical Campus |
Animal Light Cycle: | 12/12 |
Animal Feed: | CH; D12450B; Research Diets, New Brunswick, NJ, USA or HFD; D12451; Research Diets |
Animal Water: | Water or treated with 1.25 mg/L PQQ |
Factors:
Local Sample ID | MB Sample ID | Factor Level ID | Level Value | Factor Name |
---|---|---|---|---|
F1430 | SA210175 | FL025659 | HFD | Diet |
Collection:
Collection ID: | CO002270 |
Collection Summary: | Livers were excised and snap frozen then sent to the Metabolomics Core at the University of Colorado Anschutz Medical Campus for analysis following standard protocols. |
Sample Type: | Liver |
Storage Conditions: | -80℃ |
Collection Vials: | Cryotubes |
Storage Vials: | Cryotubes |
Treatment:
Treatment ID: | TR002289 |
Treatment Summary: | Dams were fed either chow (CH) or high fat diet (HFD), with or without PQQ in drinking water. |
Treatment: | HFD and PQQ |
Treatment Compound: | BioPQQ |
Treatment Route: | Drinking water, ad libitem |
Treatment Dose: | 1.25 mg/L |
Treatment Doseduration: | 6 weeks |
Treatment Vehicle: | drinking water |
Sample Preparation:
Sampleprep ID: | SP002283 |
Sampleprep Summary: | Tissue was homogenized and lipids extracted following standard protocols at the Metabolomics Core at the University of Colorado Anschutz Medical Campus. |
Sampleprep Protocol Filename: | Fetal_and_weanling_lipid_protocols.pdf |
Combined analysis:
Analysis ID | AN003586 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Thermo Vanquish |
Column | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
MS Type | ESI |
MS instrument type | Orbitrap |
MS instrument name | Thermo Q Exactive Orbitrap |
Ion Mode | UNSPECIFIED |
Units | Peak area |
Chromatography:
Chromatography ID: | CH002650 |
Chromatography Summary: | The analytical platform employed a Vanquish UHPLC system (Thermo Fisher Scientific, San Jose, CA, USA) coupled online to a Q Exactive mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA). Lipidomics analyses were performed as described in previous method papers and application notes. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640979/, https://www.haematologica.org/article/view/9990, https://pubmed.ncbi.nlm.nih.gov/31119660/ |
Methods Filename: | Fetal_and_weanling_lipid_protocols.pdf |
Instrument Name: | Thermo Vanquish |
Column Name: | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS003341 |
Analysis ID: | AN003586 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | See attached file |
Ion Mode: | UNSPECIFIED |
Analysis Protocol File: | Fetal_and_weanling_lipid_protocols.pdf |